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Abstract 
Background: Mutations of GJB2 gene encoding connexion 26 are the most common cause of hearing loss in many popula-
tions. A very wide spectrum of GJB2 gene mutations associated with hearing loss have been detected but pathogenic role 
has been tested only for a part of them. In this study, we have provided genetic evidence on the pathogenicity of our previ-
ously reported novel GJB2 allelic variants.  
Methods: The pathogenic role of GJB2 allelic variants were assessed using co segregation of each allelic variant with hear-
ing loss in family members, absence of the allelic variants in control populations, coexistence with a second GJB2 mutation, 
nature of the amino acid substitution and evolutionary conservation of the appropriate amino acid.  
Results: The GJB2 allelic variants including 363delC, 327delGGinsA, H16R and G200R have been co segregated with 
autosomal recessive non syndromic hearing loss in five families and are not found in control subjects. The G130V and 
K102Q were found in heterozygous state in two deaf individuals. G130V results in an exchange a residue highly conserved 
among all the connexins but was found with a rate of 1% in control subjects and K102Q results in an exchange a residue not 
conserved among all the connexins and not identified in control subjects. 
Conclusion: We conclude that, 363delC, 327delGGinsA, H16R and G200R may be pathogenic. However, the pathogenic-
ity and inheritance of K102Q and G130V can not be assessed clearly and remains to be identified.  
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Introduction 
Hearing loss (HL) is the most frequent neu-
rosensory disorder which is heterogenous and can 
also occur due to environmental causes. The ma-
jority of hearing deficiencies are of genetic origin, 
affecting about 60% of the HL cases in developed 
countries (1). The hereditary cases are mainly non-
syndromic and about 80% of congenital cases are 
either inherited as an autosomal recessive trait or 
apparently sporadic (2). To date more than 100 non 
syndromic hearing loss loci have been mapped 
and 39 genes have been identified (http://webh01. 
ua.ac.be/hhh). Despite the contribution of several 
different genes in causing deafness, mutations in 
the GJB2 gene (MIM# 121011), which encodes 
Connexin 26 (Cx26), have been shown to be in-
volved in the development of syndromic and 
non syndromic deafness in many populations 
(http://davinci.crg.es/deafness/). Cx26 belongs to 
a family of transmembrane proteins which forms 
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gap junction channels which is expressed in a 
variety of tissues including cochlea. Gap junc-
tions serve as a major communication system 
allowing the rapid exchange of electrolytes, sec-
ond messengers and metabolites between adja-
cent cells. It is also thought that gap junctions 
play an important role in auditory transduction, 
by recycling endolymphatic potassium ions (3-5). 
A very wide spectrum of GJB2 gene mutations 
associated with hearing loss has been detected 
(http://davinci.crg.es/deafness/) from which a few 
are found at high frequencies in some popula-
tions e.g. the 35delG in Mediterranean coun-
tries (6). The majority of the GJB2 allelic vari-
ants occur at very low frequency and a pathoge-
netic role has been tested for only a small por-
tion. However, it is of great importance to deter-
mine the molecular bases of HL in order to pro-
vide genetic counseling in high-risk families. 
Here, we have provided genetic evidence and 
investigated the likely pathogenicity of six novel 
Cx26 changes identified amongst our previ-
ously reported HL patients (7).  
 
Materials and Methods 
Subjects and control samples 
Subjects were deaf individuals harbouring 
novel allelic variants 363delC, 327delGGinsA, 
G200R, H16R, G130V and K102Q identified in 
our previous project but not assessed for the 
pathogenic role of the novel variants (7).  More-
over, we included all the available related fam-
ily members to examine the co-segregation of 
each allelic variant with hearing loss in the fam-
ily. A total of 38 subjects (five families and two 
individuals), aged between 4 and 88 yr (mean: 
36.5 yr) were studied. Medical history and pedi-
gree information were collected by a question-
naire. All patients were clinically characterised 
and checked for otoscopic and audiological ex-
amination of pure tone audiometry and were 
found to have severe to profound sensorineural 
hearing loss. The severity of the hearing loss is 
classified by the pure-tone average (PTA) at 
500, 1000, 2000 and 4000 Hz and defined as 
mild (21-40 dB), moderate (41-70 dB), severe 
(71-95 dB) and profound (PTA >95 dB) (http:// 
www.gendeaf.org). Blood samples were collected 
after obtaining informed consent from all fam-
ily members or parents of under aged subjects. 
In addition, a total of 400 anonymous blood sam-
ples without known hearing loss were collected 
from 4 provinces (100 for each region), including 
Azarbaijan Sharqi in northwest, Tehran in cen-
tral, Gilan in north and Chaharmahal va Bak-
htiari in southwest of the country based on the 
original regions in there, novel variants were iden-
tified.    
Molecular analyses  
Genomic DNA was extracted from peripheral 
blood of the family members and control sam-
ples following the standard phenol chloroform 
procedure. The GJB2 gene consists of 2 exons 
in which the first exon is non-coding. The entire 
coding sequence of GJB2 gene was PCR-ampli-
fied in all family members using the condition 
and cycling strategy has been mentioned else-
where (8, 9). Subsequently, the whole amplified 
samples were sequenced for the coding region 
(exon 2) of the gene. Sequencing of the ampli-
fied products was performed using BigDye termi-
nator V3.1 cycle sequencing kit, (Applied Bio-
systems) on an ABI 3100 DNA sequencer (Ap-
plied Biosystems). The resultant sequences were 
compared with reference sequence M86849 us-
ing SeqScape V2.0 software. 
To determine the frequency of different novel 
variants in the control populations, rapid screen-
ing assays including Amplification-Refractory Mu-
tation Screening (ARMS), Polymerase Chain Re-
action/Restriction Fragment Length Polymorphism 
(PCR/RFLP) and nested PCR were developed 
for each allelic variant (Table1). (Assays condi-
tions are available in request). 
 
Results 
Altogether, six different novel variants includ-
ing H16R, K102Q, 327delGGinsA, 363delC, 
G130V and G200R were analyzed in this study. 
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H16R was found to be compound heterozygous 
in one family originating from Azarbaijan Sharqi 
in northwest of Iran. This allelic variants results 
in an exchange of histidine at codon 16 to ar-
ginine within the intracellular 1 (IC1) domain 
(Fig. 1) of cx26 affecting a residue relatively 
conserved among all the connexins. This muta-
tion was found in a compound heterozygote state 
with a previously reported missense mutation 
(R143W). The co-segregation of H16R with 
hearing loss is shown in Fig. 2.  
The missence alteration of K102Q results in an 
exchange of lysine at codon102 to glutamine 
within the intracellular 2 (IC2) domain of cx26 
affecting a residue is not conserved among all 
the connexions (Fig. 1). This variant was found 
heterozygous in an individual from Tehran.  
The 327delGGinsA was found to be homozy-
gous in one family originating from Gilan in the 
north of the country. This frame shift mutation 
is predicted to lead to a substitutions of residues 
from codon 109 followed by premature termina-
tion at codon 111. The co-segregation of 327 
delGGinsA with hearing loss is shown in Fig. 2.  
The 363delC was found to be homozygous in six 
family members of a big pedigree originating from 
Chaharmahal va Bakhtiari in the southwest of 
the country. This frame shift mutation is pre-
dicted to lead to a substitutions of residues from 
codon 121 followed by premature termination 
at codon 167. The co-segregation of 363delC 
with hearing loss is shown in Fig. 2.  
Another novel missence alteration G130V re-
sults in an exchange of glycine to valine within 
the IC2 domain of cx26 affecting a residue con-
served among all the connexins (Fig. 1). This 
variants was found heterozygous in an individ-
ual  from Tabriz.  
The G200R was found to be homozygous in 
two families from Tehran in metropolitan. This 
allelic variants results in an exchange of glycine 
at codon 200 to arginine within the transmem-
brane (TM4) domain of cx26 affecting a residue 
not conserved among all the connexins (Fig. 1). 
The co-segregation of G200R with hearing loss 
is shown in Fig. 2.  
Moreover, the presence of 6 above mentioned 
allelic variants in control samples from differ-
ent provinces were examined using ARMS, 
PCR/RFLP and nested PCR. Analysis of con-
trol individuals revealed only the presence of 
1/100 of G130V alteration in Tabriz (Fig. 3).  
 
 
Fig. 1: Schematic representation of Connexin 26 illustrating the allelic variants studied; EC, extracellular domains; TM, 
transmembrane domains; IC, intracellular domains.  The amino acid changes are represented in dark circles. H16R, K102Q, 
327delGGinsA, 363delC, G130V are located in intracellular domains but G200R is located in transmembrane domain. 
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Table 1: Molecular assays and related conditions developed for rapid screening of 6 allelic variants 
 
Allelic  
variants:  
Methods of 
screening TM Primers 
PCR length 
(bp) 
H16R  ARMS 67 
Common 5'-CTGTCTTCACCTGTTTTGGTGAGGTTGTGT-3' 
Normal 5'-TGAGCCAGATCTTTCCAATGCTGGTGGACT-3' 
Mutant 5'-TGAGCCAGATCTTTCCAATGCTGGTGGACC-3' 
244 
K102Q  ARMS 67 
Common 5'-AGCCGCTGCATGGAGAAGCCGTCGTACATG-3' 
Normal 5'-CCATGCACGTGGCCTACCGGAGACATGAGA-3' 
Mutant 5'-CCATGCACGTGGCCTACCGGAGACATGAGG-3 
223 
327delGGinsA  nested PCR  
60 
 
56 
External F: 5' CTC  CCT  GTT  CTG  TCC  TAG  CT 3' 
External R: 5' CTC  ATC  CCT  CTC  ATG  CTG  TC 3' 
Internal F: 5' GAA  GAA  GAG  GAA  GTT  CAT  CA  3' 
Internal R: 5' CGA  TGA  CCT  TAA  ATT  CAC  TC  3' 
807 
 
53 
363delC  
PCR/RFLP:  
MboI 
 
61 CX288F: 5' CTA  CCG  GAG  ACA  TGA  GAA  GA 3' CX436R: 5' AGA  TGA  CCC  GGA  AGA  AGA  TG 3' 149 
G130V  
PCR/RFLP: 
N1aIV 
 
59 CX123F: 5' CTC  CCT  GTT  CTG  TCC  TAG  CT  3' CX929R: 5' CTC  ATC  CCT  CTC  ATG  CTG  TC 3' 807 
G200R  
PCR/RFLP: 
XbaI 
 
59 CX123F: 5' CTC  CCT  GTT  CTG  TCC  TAG  CT  3' CX929R: 5' CTC  ATC  CCT  CTC  ATG  CTG  TC 3' 807 
a  
H16R                                       
 
b 
327delGGinsA 
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c 
G200R 
                
       
d 
363delC 
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Fig. 2: Pedigrees and audiograms of five families segregating GJB2 gene allelic variants.  An average levels of hearing 
losses of both ears have been shown at 250-8000 Hz. ‘+’ represent the mutant chromosome, ‘-’ represent the wild type and 
‘N’ indicates DNA unavailable. (a) Co-segregation of  H16R and the average level of hearing loss in a family from Azarbai-
jan Sharqi (b) Co-segregation of 327delGGinsA  and the average level of hearing loss in a family from Gilan. (c) Co-
segregation of G200R and the average level of hearing loss in two families from Tehran.  (d) Co-segregation of 363delC 
and the average level of hearing loss in a family from Chaharmahal va Bakhtiari. 
 
a 
 
b 
 
c 
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e 
 
 
f 
 
 
 
Fig. 3:  ARMS, PCR/RFLP and nested PCR assays were developed for rapid screening of 6 allelic variants. ‘Wt’ represents 
the wild type, ‘Hom’ represents the homozygote, ‘Het’ represents the heterozygote, ‘M’ represents the marker (ladder), ‘Ne’ 
and ‘ND’ indicate no restriction enzyme and no DNA respectively. (a and b) ARMS screening of H16R and K102Q allelic 
variant respectively. Lanes 1 show negative controls (no DNA), Lanes 2 and 3 represent control heterozygotes amplified by 
mutant and normal primers respectively. Lanes 4 and 5 represent control normal DNAs amplified by mutant and normal 
primers respectively. ARMS results of DNA samples using mutant and normal primers are shown in lanes 6, 8 and 7, 9 
respectively. Lanes 10 show ladder size strands. The lower bands and upper bands in fig a and b represent the 149bp and 
244bp control products respectively. (c) nested PCR screening of 327del GG insA allelic variant. wild type, Homozygote 
and heterozygote alleles were detected as one or two bands of 52 and 53bp. (d) Screening of 363delC allelic variant by 
PCR/RFLP. The normal 149bp PCR product is digested with MboI to give products of 72 and 77bp. This mutation destroys 
the MboI resetriction site. (e)  PCR/RFLP for screening of G130V allelic variant. The N1aIV digests the normal 807bp PCR 
product in two sites giving three fragments of 341, 308 and 158bp. This mutation destroys the N1aIV restriction site in one 
of two positions giving two strands of 499 and 308bp. (f) Screening of G200R allelic variant using PCR/RFLP assay. This 
mutation creates a XbaI restriction site. Therefore, the mutant 807bp PCR product is digested with XbaI to give products of 
671 and 136bp. 
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Discussion 
Our previous review on 3214 chromosomes of 
autosomal recessive non syndromic hearing loss 
families revealed a specific combination of GJB2 
mutations types and frequencies in different re-
gions of Iran. The average of 16.1% of GJB2 
mutations in familial and sporadic deaf chromo-
somes (with a gradual decrease of its frequency 
from north and northwest to the south and 
southeast) were detected. We determined 35delG 
as the most prevalent GJB2 mutation, account-
ing for 71.6% of the GJB2 mutations chromo-
somes with a carrier frequency of.1.25%. The 
R127H, W24X, delE120, -3170G>A and V27I+ 
E114G were the following common mutations 
in different population of Iran (7, 10). While the 
prevalence of GJB2-related deafness in Iran is 
2-3 times less than that reported from European 
populations, mutations of this gene are the ma-
jor cause of deafness reported so far. Moreover, 
six novel GJB2 allelic variants H16R, K102Q, 
327delGGinsA, 363delC, G130V and G200R were 
detected in our previous study which has been the 
subject of this study regarding their pathogenicity 
(7). A novel variant with autosomal recessive non 
syndromic hearing loss inheritance supposed to 
be a pathogenic allele if the following factors 
would be considered: co segregation with hear-
ing loss in different families, absence of the mu-
tation in 100 non-deaf control subjects, coexis-
tence with a second GJB2 mutation, nature of 
the amino acid substitution and evolutionary con-
servation of the amino acid residues over several 
species and across different connexins (11-13).  
Co-segregation of novel allelic variants with deaf-
ness in several different family members could 
clarify the inheritance pattern and pathogenic 
role of each variant. We found four of six allelic 
variants H16R, 327delGGinsA, 363delC, and 
G200R homozygous or compound heterozygous 
co-segregating with congenital bilateral severe to 
profound hearing loss in several family members. 
The remaining two allelic variants K102Q and 
G130V were heterozygote found as the sole vari-
ants in two deaf individuals which co-segrega-
tion studies could not be performed for them. 
The failure of our previous study to detect the 
second allele of these heterozygote GJB2-related 
patients might be due to mutation in non-coding 
region of the gene that we did not screen. It could 
be also due to another connexin gene such as GJB6 
or interaction with other gene product. How-
ever, more than 500 deaf subjects have been tested 
for a large deletion of the GJB6 gene namely del 
(GJB6-D13S1830) in Iran, but no mutation has 
been detected (14-16). These heterozygote GJB2-
related patients might be a simple carrier and 
their deafness may have another cause (17-19). 
In summary; four of six allelic variants H16R, 
327delGGinsA, 363delC, and G200R have been 
co segregated with autosomal recessive non syn-
dromic hearing loss in five families and are not 
found in control subjects. Moreover, two frame shift 
alterations 327delGGinsA and 363delC predicted 
to lead to truncated proteins and H16R was 
found coexisted in trans with a previously re-
ported missense mutation allele R143W causing 
profound hearing impairment. We conclude that, 
H16R, 327delGGinsA, 363delC and G200R are 
responsible for the deafness phenotype and may 
be pathogenic. However, the pathogenicity and 
inheritance of K102Q and G130V can not be sug-
gested clearly by our data and remains to be 
identified. The data presented here will improve 
the genetic counselling of hearing impaired patients. 
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